Published in Br J Cancer on December 08, 2009
The genetic epidemiology of prostate cancer and its clinical implications. Nat Rev Urol (2013) 1.39
A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations. Cancer Epidemiol Biomarkers Prev (2010) 0.94
Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer. PLoS Genet (2014) 0.93
Germline genetic profiling in prostate cancer: latest developments and potential clinical applications. Future Sci OA (2015) 0.75
The rs10993994 in the proximal MSMB promoter region is a functional polymorphism in Asian Indian subjects. Springerplus (2015) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet (2001) 22.07
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet (2008) 15.43
MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics (2005) 11.75
Prostate cancer epidemiology. Lancet (2003) 6.30
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst (1994) 6.27
Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A (1992) 3.28
Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess (2003) 3.25
Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet (2009) 1.90
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A (2009) 1.81
Strong bias in the location of functional promoter polymorphisms. Hum Mutat (2005) 1.48
Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy. Clin Cancer Res (2006) 1.43
Unravelling the genetics of prostate cancer. Am J Med Genet C Semin Med Genet (2004) 1.38
Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis. Prostate (1999) 1.26
Genetic predisposition to prostate cancer. Prostate Cancer Prostatic Dis (1999) 1.12
Age specific and attributable risks of familial prostate carcinoma from the family-cancer database. Cancer (2002) 0.95
Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer. Hum Genet (2009) 0.88
Human gene for beta-microseminoprotein: its promoter structure and chromosomal localization. J Biochem (1995) 0.78
PSA and prostate cancer screening: the challenge of the new millennium. Eur Urol (2007) 0.78
The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell (1992) 30.02
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell (1992) 28.36
Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell (1995) 24.99
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature (2001) 11.72
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ (1990) 10.93
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Rho GTPases and their effector proteins. Biochem J (2000) 8.89
Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol (1999) 8.66
Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell (2001) 7.07
An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science (1995) 6.03
Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia. Emerg Infect Dis (2001) 5.65
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet (1998) 5.35
Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell (1996) 5.34
Interplay between Rac and Rho in the control of substrate contact dynamics. Curr Biol (1999) 5.29
Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature (1991) 5.16
The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J Cell Biol (1997) 5.15
Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science (1998) 4.92
Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet (1995) 4.86
Microinjection of recombinant p21rho induces rapid changes in cell morphology. J Cell Biol (1990) 4.83
Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol (1997) 4.72
A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases. J Biol Chem (1995) 4.62
Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol Cell Biol (1995) 4.60
Structural barriers and facilitators in HIV prevention: a review of international research. AIDS (2000) 4.53
The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product. Nature (1988) 4.33
Population requirement for primary hip-replacement surgery: a cross-sectional study. Lancet (1999) 4.29
Ras and Rho GTPases: a family reunion. Cell (2000) 4.21
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet (1997) 4.16
Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature (1983) 3.86
Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature (1980) 3.78
Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet (2001) 3.75
Phosphatidylinositol 4,5-bisphosphate induces actin-based movement of raft-enriched vesicles through WASP-Arp2/3. Curr Biol (2000) 3.75
Psychological effects of being offered choice of surgery for breast cancer. BMJ (1994) 3.48
Normal p21N-ras couples bombesin and other growth factor receptors to inositol phosphate production. Nature (1986) 3.41
Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ (1998) 3.37
Rho GTPases. J Biol Chem (1998) 3.35
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol (2001) 3.35
Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet (1995) 3.33
The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases. J Cell Biol (1995) 3.33
Signal transduction pathways regulating Rho-mediated stress fibre formation: requirement for a tyrosine kinase. EMBO J (1994) 3.26
Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess (2003) 3.25
Intracellular localization of the P21rho proteins. J Cell Biol (1992) 3.21
The development of a multi-disciplinary approach to the assessment and management of child sexual abuse in an inner city Health District. Health Trends (1988) 3.21
Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health. BMJ (1996) 3.18
Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr Biol (1996) 3.13
Cdc42 controls secretory and endocytic transport to the basolateral plasma membrane of MDCK cells. Nat Cell Biol (1999) 3.12
Role of actin polymerization and adhesion to extracellular matrix in Rac- and Rho-induced cytoskeletal reorganization. J Cell Biol (1997) 3.12
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09
Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol (1986) 3.07
Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature (1984) 3.06
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet (1994) 3.05
The ELF3 zeitnehmer regulates light signalling to the circadian clock. Nature (2000) 3.05
Dynamic fatty acylation of p21N-ras. EMBO J (1987) 2.99
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet (1996) 2.97
Directed selective pressure on a beta-lactamase to analyse molecular changes involved in development of enzyme function. Nature (1977) 2.93
Attendance of general practitioners at child protection case conferences. BMJ (1991) 2.90
Bcr encodes a GTPase-activating protein for p21rac. Nature (1991) 2.90
The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol (2000) 2.89
Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. Emerg Infect Dis (1996) 2.83
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J Cell Sci (1995) 2.80
URINARY EXCRETION OF THIAMIN IN CLINICAL CASES AND THE VALUE OF SUCH ANALYSES IN THE DIAGNOSIS OF THIAMIN DEFICIENCY. J Clin Invest (1940) 2.77
Diagnosis, management and screening of early localised prostate cancer. Health Technol Assess (1997) 2.74
Risk of lymphoedema following the treatment of breast cancer. Br J Surg (1986) 2.73
Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene (2007) 2.68
The oral examination: a study of academic and non-academic factors. Med Educ (1993) 2.65
Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity. Science (1994) 2.65
Cdc42 induces filopodia by promoting the formation of an IRSp53:Mena complex. Curr Biol (2001) 2.54
Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five North European countries. Br J Cancer (2005) 2.54
A requirement for Rho and Cdc42 during cytokinesis in Xenopus embryos. Curr Biol (1997) 2.53
The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol (1996) 2.50
Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant (2006) 2.47
Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans (1995) 2.43
neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol (1998) 2.42
Human N-ras: cDNA cloning and gene structure. Nucleic Acids Res (1985) 2.41
Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A (1983) 2.38
An ordered comparative map of the cattle and human genomes. Genome Res (2000) 2.38
A new member of the Rho family, Rnd1, promotes disassembly of actin filament structures and loss of cell adhesion. J Cell Biol (1998) 2.36
Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases. Curr Biol (1996) 2.36
Rho- and rac-dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin/radixin/moesin proteins. J Cell Biol (1997) 2.35
Teaching senior oncologists communication skills: results from phase I of a comprehensive longitudinal program in the United Kingdom. J Clin Oncol (1998) 2.34
Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis (2001) 2.34
rho family GTPase activating proteins p190, bcr and rhoGAP show distinct specificities in vitro and in vivo. EMBO J (1993) 2.31
Comparative advantage of 3-day food records over 24-hour recall and 5-day food frequency validated by observation of 9- and 10-year-old girls. J Am Diet Assoc (1994) 2.30
Involvement of the Arp2/3 complex in phagocytosis mediated by FcgammaR or CR3. Nat Cell Biol (2000) 2.29
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer (2011) 2.28
Surgical aspects of continuous ambulatory peritoneal dialysis--3 years experience. Br J Surg (1984) 2.28
Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet (1998) 2.27
A prospective longitudinal study of social, psychological and obstetric factors in pregnancy: response rates and demographic characteristics of the 8556 respondents. Br J Obstet Gynaecol (1989) 2.27
Survival trends for patients with AIDS. JAMA (1990) 2.24
Purification of recombinant Rho/Rac/G25K from Escherichia coli. Methods Enzymol (1995) 2.23
The rho gene product expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3. Biochem Biophys Res Commun (1989) 2.23
Increasing cataract surgery to meet Vision 2020 targets; experience from two rural programmes in east Africa. Br J Ophthalmol (2005) 2.22
IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J (1999) 2.20
Signaling to Rho GTPases. Exp Cell Res (1999) 2.19
Post-translational modifications of p21rho proteins. J Biol Chem (1992) 2.17
Familial cancer syndromes. Lancet (1994) 2.16